safingol has been researched along with Diabetes Mellitus, Type 2 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurano, M; Sakai, E; Tsukamoto, K; Yatomi, Y | 1 |
| Chabowski, A; Górski, J; Kurek, K; Mikłosz, A; Żendzian-Piotrowska, M; Łukaszuk, B | 1 |
| Chen, W; Hang, W; Huang, B; Lin, L; Song, X; Yan, L; Yan, X; Zhang, J | 1 |
| Baranowski, M; Dobrzyń, A; Górska, M | 1 |
4 other study(ies) available for safingol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Differences in the Distribution of Ceramides and Sphingosine among Lipoprotein and Lipoprotein-Depleted Fractions in Patients with Type 2 Diabetes Mellitus.
Topics: Cardiovascular Diseases; Ceramides; Chromatography, Liquid; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Sphingolipids; Sphingosine; Tandem Mass Spectrometry; Triglycerides | 2022 |
Inhibition of Ceramide De Novo Synthesis Ameliorates Diet Induced Skeletal Muscles Insulin Resistance.
Topics: Animals; Ceramides; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Fatty Acids, Monounsaturated; Glycolysis; Insulin Resistance; Lysophospholipids; Male; Muscle, Skeletal; Oxygen; Rats; Rats, Wistar; Signal Transduction; Sphingolipids; Sphingosine | 2015 |
Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system.
Topics: Adult; Aged; Biomarkers; Chromatography, High Pressure Liquid; Cluster Analysis; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Leucine; Male; Metabolome; Metabolomics; Middle Aged; Principal Component Analysis; Spectrometry, Mass, Electrospray Ionization; Sphingosine | 2009 |
Concentrations of sphingosine and sphinganine in plasma of patients with type 2 diabetes.
Topics: Aged; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Humans; Male; Middle Aged; Sphingosine | 2005 |